Reddit Posts
Any advice on what to YOLO on this week?
How I am Positioning myself in the Markets going into 2024
Does FSR really look like a buy or YOLO?
What's a better long term buy now. BMY vs. PFE?
Seeking suggestions on companies to swap DIS, PFE and BMY with in year end tax loss harvesting
$RNXT $1.00 +25.63% #Cancer #Treatment #Research
$PFE Pfizer down 8% since Cramer’s buy call 12 days ago
What stocks are under additional pressure in December due to tax loss harvesting?
Cramer shuffling papers this morning over $PFE
@PFE Pfeizer 5.5% Yield with January Effect and Weight loss pill testing
Why wouldn't you invest a large amount of money into Pfizer right now and ride it out for a few years?
Long time investment, estimated rocketing by 2025 [CYBN]
7 Diabetes and Weight Loss Drug Stocks With Big Potential
$RGBP Must read mRNA #FDA in play!
Down 11% on taxable account. Planning on buying a house in the next 2.5-3 years. Should I sell or change strategies?
I told you so 5 months ago - NO RECESSION NO PIVOT
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
CDC: New Variant BA.2.86 More Capable of Causing Infection In Those Previously Vaccinated or Infected
Bull Case Through EOY : Pfizer ($PFE)
WSJ: Pfizer’s Covid Boost Crashes to Earth. "Shares are down 31% YTD, a loss of more than $88 billion in market capitalization"
Post-COVID Era Plays (Lessons from $PFE earnings)
what does it mean if a company has over 100% institutional ownership
Bull Thesis for Dr Reddy’s Laboratories (NYSE: RDY)
$SGEN spread at 15% now looking like steal of a Merger play
What to do for Pfizer's Earnings tomorrow morning
Why I'm not playing LOGI Earnings Tonight
Stocks could soar in the 'return to work from home' play as BNTX vaccine shown to be 4% effective vs circulating XBB Variant in new study
Stocks Set To Soar As Bivalent Vaccine Found 4% Effective Vs XBB Covid Variant
Johnson & Johnson Earnings Are Here: Should You Buy?
Tiziana Life Sciences $TLSA is Bracing for an Explosive 2023
The Catalysts Behind Tiziana Life Sciences' (NASDAQ: TLSA) 70%
Mirati | Investors are to Fight Losses from $MRTX downfall.
Pfizer, Astellas avoid forced price reduction for cancer drug Xtandi (NYSE:PFE)
Pfizer CEO pockets $33M for 2022 after 36% pay hike (NYSE:PFE)
AbbVie, Gilead, Seagen fined for raising prices faster than inflation (NYSE:PFE)
Pfizer faces resistance in plans to modify EU COVID vaccine deal (NYSE:PFE)
Pfizer COVID pill effective on Omicron; not linked to disease rebound – FDA (NYSE:PFE)
Pfizer deal to acquire Seagen sends cancer drug maker's shares 18% higher (NYSE:PFE)
Biosimilars expected to save $180B over next five years as more gain approval (NYSE:PFE)
Pfizer, GSK gearing up for RSV vaccine rollouts this year (NYSE:PFE)
U.K. announces spring COVID booster program for at-risk individuals (NYSE:PFE)
Biden to announce plan to keep Medicare solvent beyond 2050 (NYSE:PFE)
Flu and COVID combo shots unlikely this year, FDA’s top vaccine official says (NYSE:PFE)
FBI Director says novel coronavirus likely originated from China lab leak (NYSE:PFE)
$AIM Try to name another bio stock in trials with $BMY $MRK $AZN and PFE.
Hot Stocks: SGEN climbs on takeover interest; PFE sets 52-week low; TGNA drops; KOS rises
Pharma companies dominate list of innovation leaders thanks to patents (NYSE:PFE)
Pfizer(PFE): Says Pipeline Of Drugs Will Ease Transition From COVID.
Pfizer to face FDA AdCom meeting for full approval of COVID-19 pill (NYSE:PFE)
Completed head and shoulders on PFE? Time to short?
Pfizer, BioNTech start trial for first mRNA-based shingles vaccine (NYSE:PFE)
Medicare mulls rebates in 2025 for drug prices rising faster than inflation (NYSE:PFE)
Pfizer/BioNTech, EU in talks to cut COVID vaccine deliveries for higher prices (NYSE:PFE)
PFE stock falls as Pfizer downgraded at UBS on COVID worries (NYSE:PFE)
Omicron boosters protect against new COVID strains up to three months - CDC (NYSE:PFE)
FDA plans an annual schedule for updated COVID shots (NYSE:PFE)
2023-01-16 Wrinkle-brain Plays (Mathematically derived options plays)
2023-01-16 Wrinkle-brain Plays (Mathematically derived options plays) DD
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE)
Thoughts on shorting MRNA and PFE
Mentions
Eventually the market will crucify NVO and LLY just like it did PFE and MRNA. The vax went out of favor even though they assumed people would take it for life and so will Mounjaro and Ozempic. I predict The gov will crack down on both because of price gouging and health affects. They're building new factories to make this drug just like PFE and MRNA did and the demand will eventually tank. People taking them look terrible, and there are many GI issues related to taking it. LLY and NVO are trading above 16 p/s which is crazy for a massive drug company. Revs are growing because they are charging ridiculous amounts. I predict a public backlash very soon. My 2 cents.
Investors wants what LLY is producing, PFE is basically dead money.
PFE is lower than 1996
Berkshire has sold some of its stake, which it bought in the low $30's. There are a lot of shareholders who are upset about what has resulted with this deal and I've read a number of various upset letters fund managers have written. Still, given the history of the company and a controlling shareholder, should this result really be that surprising? IMO - and I'm not always right by any means - pure play media is one of those things where I've continually been happy to miss it because I don't like the business - LGF, AMCX, this, WBD - there's no history of really delivering for shareholders. People can make cases for IP value but you have a bunch of companies that didn't monetize that value when streaming was in a golden age a while ago. Now after going their own way and making all of these seperate services that didn't have the NFLX growth story they were hoping for and streamers are cutting spending, they're expected to monetize the IP well? If I don't like the business and the business isn't operating from a position of strength, is a deal going to be that exciting? What if a deal doesn't happen and I buy it because I think it looks cheap and a year later all it's done is head South? All people have gotten with this and WBD is frustration and the much hoped for deal for PARA so far is more frustration. Various fund managers are going to probably turn this into a long battle if they don't get their way, but again, Sheri is the controlling shareholder and maybe there's some sort of compromise reached eventually, but it's probably not going to be what shareholders hoped for, especially after poor returns for the last year/5 year periods. So maybe there's a more appealing deal after a long, dragged out battle between some fund managers and the controlling shareholder but it's probably not going to be what was hoped for or Sheri's the controlling shareholder and winds up getting her way. Hopefully PARA shareholders eventually wind up with a better deal but stuff like this, PFE, BABA and all the other stuff people have tried to call bottoms on here all year - really examples of cheap for a reason/cheap can get much cheaper than people expect, especially without a catalyst and good management.
I liked it at 38, you can bet I've been buying all the way down, including yesterday. PFE is trading at $10 over book value. They have a safe dividend over 6%. I think they will announce buybacks soon. Combined with any good news on anything in their pipeline and this will go up quickly. almost 70% institutional ownership, when retail catches up on what is going on, the price will go up. Big players have big stakes in this. Pfizer is not going away and they are very cheap right now.
Everybody talking about PCE when you should be looking at PFE
I don’t know. PFE dicked me today
655 shares at \~$108. I bought as much as I could over the past few years and it's nice to see it paid off. Now, if only I hadn't bought all that PYPL and PFE...
PFE 6/21 26c for .68 be my guest
How we feeling on PFE earnings on thursday? Puts? Calls? thinking puts, so I’ll do calls
How we feeling on PFE earnings on thursday? Puts? Calls? thinking puts, so I’ll do calls
Is PFE worth less now than in 2012? At 70% institutional ownership and over 6% dividend, when it goes, she gone. $10 over book value/share with blockbusters in the pipe.
Ehh it's not really PFE's fault for a drug candidate failing. That's just how the industry is, you can never guarantee something will pass all the requirements, as promising as the science might be. The approval process is notoriously hard even for the biggest pharma companies. Besides they still have a candidate in play for weight loss, and the data on it should be coming out in a few weeks. Feels like failure is already being priced in anyway so any positive surprise will be a boost.
INTC doing INTC things -9% after earnings. The cheap and "known" play on something is often cheap for a reason (see also: all the people on here last year who kept incessantly arguing that PFE was the cheaper and therefore better obesity drug play than LLY/NVO, only to have the drug trial be a flop.)
I don't--investing isn't about emotion or conscience, investing is about making money. I have no ties whatsoever to NVDA, BRK.B, RTX, DG, Alphabet, PFE, JPM, LLY, XOM, and others because more often then not they make me way way more money then they cost me. I have no direct connection to most any of their products. Now, I choose not to invest in Tobacco companies because I find it repugnant...but that's hardly a moral stance.
When will PFE cut dividends? Tryna load up cheap
PFE must be the worlds doggiest large cap. Literally no good news now getting sued by GSK for using its IP to develop mRNA Covid vaccines lol Headed for 20 bucks.
Banked $1200 on /ES Puts this am closed out the PFE calls sold. Waiting for another set up
PFE returns 1% regularly...it takes time to research the "middle ground no scanner will give you this automatically, and if there is a scanner like that, the opportunity will diminish quickly.
Not for the names I want to own though lol. I’ve found it very hard to find a middle ground. Names like TSLA, MSFT, AMD always offer good premium. I would never want to take assignment though, especially not right now. Then have names like MO, PFE, ENB more dividend growth stocks that pay barely anything and aren’t worth it. That’s why a scanner might be useful I guesss. I’ve had trouble finding a “middle ground”
Shouldhave bought before SOLVdoistribution. If we include SOLV, I'm up a lot. If we exclude SOLV, I'm up 1%. I bought at 91.28. really expecting MMM to recover in the long term and the dividend yield of 6%+ same as PFE is good enough for me. I suggest waiting until earnings so that the stock reflects any change in dividends. I'm also waiting until earnings to see if I want to hold SOLV or not.
PFE - at this price - just above bottom price $25.5, I keep adding PFE for dividends. Fundamentally they maintain the forecast. On any case, wsb has a not the blog for it!!’
What’s your investment thesis for owning PFE? You seem pretty enthusiastic about the company lol
BTSG WBA PFE to the moon!
I plan on closing some PFE calls I sold today. Looking for 30%
PFE has had 2 green days in a row. It needs a 5% correction, this is too much ![img](emote|t5_2th52|51295)
PFE basically at 5 year lows. paying a nice dividend. deep value or heavy bags?
PFE Dividend up to 7%
JNJ PFE UNH up today
i Bought WBA, UNG, PFE, CSCO, BMY, VALE, and Swiss Chocolate... i'm full GREEEEEEN !!!!
What about ZM? Earnings beats every quarter last few years. Balance sheet is immaculate. $7 billion cash $70 million debt I’m watching ZM, SNOW, ZS, PFE, TSLA, SHOP, PYPL
Have an IRA & a fun account. I'm buying the shit outta PFE at these levels in the ROTH. PFE is the definition of boring though
> What's everyone's take on pfizer? Stagnant dinosaur. " it seems a bit oversold now" It's below where it was 20 years ago. It is oversold in the short-term but people ignoring the fact that the long-term has been unacceptable for more than a couple of decades now. Maybe you get a short-term bounce, but people keep saying that PFE is cheap and the concern I have is that - with everything the same - why does the next 3-5-10 years for PFE look any different than the last? I've called PFE the Immelt-era GE of pharma and like GE, it needs a revamp and new leadership a la Culp/GE. "great dividend" Don't buy something for the dividend.
"but at a certain point the market is being way too backwards-looking about the fading away of Covid related demand." At some point the stock becomes overhated, but about 20 years of extremely mediocre returns should still absolutely weigh on outlook - maybe it bounces, but without a catalyst it's difficult to get excited beyond that. Replace management with someone compelling a la GE/Culp (and imo PFE really is the Immelt-era GE of pharma) and I'd be interested. Otherwise... "At the end of the day, though, Pfizer got a massive cash pile that most other pharma companies didn't, enabling it to buy more products / research pipelines" The market is telling you it doesn't have confidence in Pfizer's ability to buy growth - it has overpaid for growth more than a few times, including the failed attempt to buy Allergan, which was bought by Abbvie a few years later for less than half of what Pfizer was offering - government blocking it saved PFE from themselves.
Really starting to think PFE is getting stupid cheap, and narrative is following the price. The problem is they are a huge black-box when it comes to the success of their pipeline, but at a certain point the market is being way too backwards-looking about the fading away of Covid related demand. Covid was a huge success for Pfizer, not a failure. That huge success is making YoY figures look terrible and temporarily compressing margins. At the end of the day, though, Pfizer got a massive cash pile that most other pharma companies didn't, enabling it to buy more products / research pipelines. Yet it saw major multiple compression. Question is: do I trust that some subset of their huge portfolio will be a big hit, and am I satisfied with a 6% dividend yield while waiting for it to materialize? At this current price.... yes I think. But I'm hesitant. Reposting my comment from 11 days ago: > Covid was such a massive aberration to the business that I don't really trust using these 3 year trailing figures. [I made this MS Paint](https://i.imgur.com/1gvRTNW.png) diagram. The black line is actual revenue. Green is Y/Y change. Right now revenue looks awful because the Covid bump is over. But in the absence of Covid, you would have seen the dotted line instead. It actually would be worse, because the Covid cash infusion allowed it to go on a buying spree and thus increase future revenue growth. So the positive events that allowed Pfizer to increase its moat make it seem that Pfizer is actually worse off. But that can't be true. > > Right now Pfizer is being forced to throw in all kinds of non cash accounting adjustments to reflect the fact that it was hard to accurately keep track of orders that eventually got cancelled when the Covid demand subsided. So margins/EPS all look awful. But it's showing a very misleading picture of the fundamental business in the future. > > The right way to value Pfizer is to guess what the 'normal' revenue/earnings are going to look like once all the Covid comparables fully fade away and the accounting adjustments are complete. Not look at probably the most insane time period that could have ever happened to a pharma company and what that makes the trailing numbers look like as a result.
Pfizer + J&J hit 52 week lows. Can anyone tell me what's going on with $PFE and $JNJ recently? Pfizer is already lower than its 2013 low.
PFE SAME VALUE 2014 ![img](emote|t5_2th52|4271)
If you look up dead money in the dictionary, you get PFE
Like buying calls on PFE for getting people hard.
I think PFE switch to being a mining company. They drilling to the earths core
Just a correction. Yes stocks should go down when yields go up but not my the percentage but rather by the percentage point. Sp500 should be down higher than the 1% in the past month. Now is a good time to enter the market. I'm going to move money from savings and am looking for something to provide more than a 5% yield. I'm thinking BNS.TO, IIPR, BTI, PFE, NEP, and if it comes down SCM. I was considering a covered calls strategy on roku but we'll see how volatile it'll be post earnings.
My portfolio: PTON, RIVN, BIRD, PFE
LLY is >$200B over valued. Them and NVO gonna be the next PFE/MRNA. Not ok to inject this shit and f’up your digestive system. Lawsuits will come.
$PFE, $RC, $HOOD (should’ve known better on that last one) I’m particularly upset about $RC because I’ve been averaging down on it for more dividend and expecting it to jump up “eventually”. I mean, real-estate doesn’t have much risk, right? (/s) I have a small portfolio though, so it’s cool. It’s just disappointing to see Red when I zoom out to a month. Still in the green for 1 year though
Ticker Symbol: JPM P/E: 11.27 P/E Rank: 83.53 P/S: 3.08 P/S Rank: 38.18 P/B: 1.77 P/B Rank: 59.49 P/FCF: 40.46 P/FCF Rank: 43.29 SHYield: 4.31% SHYield Rank: 74.24 EV/EBITDA: 10000.00 EV/EBITDA Rank: 16.44 Overall Score: 315.18 6 month price momentum: 25.07% Ticker Symbol: META P/E: 34.36 P/E Rank: 50.42 P/S: 9.67 P/S Rank: 15.39 P/B: 8.56 P/B Rank: 16.07 P/FCF: 29.76 P/FCF Rank: 48.84 SHYield: 1.83% SHYield Rank: 55.87 EV/EBITDA: 20.81 EV/EBITDA Rank: 46.82 Overall Score: 233.41 6 month price momentum: 56.15% Ticker Symbol: VRTX P/E: 28.55 P/E Rank: 55.11 P/S: 10.41 P/S Rank: 14.65 P/B: 5.81 P/B Rank: 22.43 P/FCF: 30.70 P/FCF Rank: 48.00 SHYield: 0.29% SHYield Rank: 41.75 EV/EBITDA: 20.55 EV/EBITDA Rank: 47.21 Overall Score: 229.15 6 month price momentum: 8.57% Ticker Symbol: GOOGL P/E: 27.17 P/E Rank: 56.83 P/S: 6.38 P/S Rank: 20.90 P/B: 6.94 P/B Rank: 19.32 P/FCF: 28.22 P/FCF Rank: 50.21 SHYield: 3.04% SHYield Rank: 65.25 EV/EBITDA: 18.77 EV/EBITDA Rank: 49.93 Overall Score: 262.45 6 month price momentum: 12.22% Ticker Symbol: PFE P/E: 71.95 P/E Rank: 39.96 P/S: 2.50 P/S Rank: 44.58 P/B: 1.64 P/B Rank: 62.43 P/FCF: 30.47 P/FCF Rank: 48.25 SHYield: 6.57% SHYield Rank: 86.33 EV/EBITDA: 18.14 EV/EBITDA Rank: 50.99 Overall Score: 332.55 6 month price momentum: -21.90% Ticker Symbol: PYPL P/E: 16.79 P/E Rank: 71.90 P/S: 2.29 P/S Rank: 47.42 P/B: 3.29 P/B Rank: 36.66 P/FCF: 16.11 P/FCF Rank: 65.00 SHYield: 6.69% SHYield Rank: 86.87 EV/EBITDA: 12.31 EV/EBITDA Rank: 66.68 Overall Score: 374.52 6 month price momentum: 11.23% Ticker Symbol: TSN P/E: 10000.00 P/E Rank: 17.15 P/S: 0.38 P/S Rank: 92.82 P/B: 1.11 P/B Rank: 79.22 P/FCF: 34.45 P/FCF Rank: 45.58 SHYield: 3.56% SHYield Rank: 69.14 EV/EBITDA: 13.90 EV/EBITDA Rank: 61.90 Overall Score: 365.81 6 month price momentum: 19.85% Ticker Symbol: QCOM P/E: 24.82 P/E Rank: 59.68 P/S: 5.27 P/S Rank: 24.17 P/B: 8.31 P/B Rank: 16.58 P/FCF: 19.33 P/FCF Rank: 60.00 SHYield: 3.01% SHYield Rank: 64.83 EV/EBITDA: 17.93 EV/EBITDA Rank: 51.30 Overall Score: 276.55 6 month price momentum: 54.15% I don't have a GitHub directory, but it's not a bad idea to create one! I've got a couple different ML-based financial modelling projects I've been tinkering on, but they're definitely not ready for sharing.
Thanks, OP. May I have an analysis on the following: JPM, META, VRTX, GOOGL, PFE, PYPL, TSN, QCOM. Also, is there a link to the Github code? Thank you so much for your scientific contribution!!
Thanks, OP. May I have an analysis on the following: JPM, META, VRTX, GOOGL, PFE, PYPL, TSN, QCOM. Also, is there a link to the Github code? Thank you so much for your scientific contribution!!
INTC, PFE, T: all the same boat. High debt dinosaurs that our infrastructure relies upon, but has no prospect of share appreciation until they get leaner. They should fire their board, break up their companies, and then watch shares of the new leaner companies shoot up.
Those are in my YOLO speculation portfolio. In my main one I have a good bit of PFE at 27 cost basis and about 30 shares of BMY. Been debating on LLY or another for my next one. However, EDIT and DNA are in a portfolio worth about 4% of my main one all told. I'm not too worried, but I do agree. Rational picks are more established potential value plays.
I most certainly wouldn't consider myself 'more experienced', but I spent 2021 to around late 2023 down quite a bit on a lot of picks of mine. In time you learn to cut the losers - it can be easy to get attached and hold on too long, but learning to let go really is an important skill. Looking at your list there I think MSFT TSM and PFE are good holds (I hold MSFT myself , have been contemplating buying some PFE, and *should have* bought TSM back in 2021), and PVH it could go either way. NOVA is definitely going to be your biggest troublemaker. Renewables, electric cars, anything of that sort... just isn't ready. Either that, or knowing which one will succeed is like shaking a magic eight ball - while NOVA may be your biggest holding one day, it will probably also be the one you're going to be down the most on for the longest period of time. (From my experience.) TL;DR: just be vigilant and try not to get attached to whatever is killing you.
My PFE chart is nasty. I bought in Dec 2022 after they had such a nice gain over the previous two months that I thought PFE was finally over stepping on their own feet. I was wrong.
My buy low and wait stocks are PFE, MMM. Looking closely at SBUX and SNOW.
I have a proposal for the ugliest chart ever: PFE
PFE is a good one especially now at this price. A lot of divi stocks fairly priced, so good ones still are MMM, PFE, BGS, ENB, BMG, things like that
Anyone buying UHN HUM JNJ PFE or are these companies washed up Dead ☠️?
Josh Brown still holding PFE?
PFE HUM UNH JNJ all beat up
The rocket tips are filled with Viagra to overcome their impotence. Calls on Pfizer (PFE).
I have 225k in TTTXX (treasuries only fund) and long term safe places plus 30k in cash. I then have about 70k in Robinhood just to play around shorter term with individual stocks. I started that about a week ago…bad timing I guess. I have 20k in SPY, and 10k each in: -PVH -PFE -MSFT -TSM -NOVA Everything is down. NOVA is way down. The first several days I kinda freaked out at every rise and fall. Now I’m thinking to just stop worrying so much and just stick with these and ride the rises and falls for a while. This is my “play” money and part of my mindset is I want to invest in companies I believe in (hence NOVA for solar, TSM to support my former home Taiwan, and not investing in tobacco, fossil fuels for example) but I still want to gain and hopefully beat the market. I feel like despite being a novice I researched these stocks pretty decently and feel like they have good prospects. But the pain from NOVA especially has me questioning my life choices a bit. Any tips from the more experienced among you?
Asking for a friend who is a toddler: why do millions of shares of PFE change hands in the first minute of post market every day for months now?
It can go lower. You’re better off buying GME or PFE if you want to find 52 week low deals and sell CC to make money while waiting for the rise.
currently in $PFE 29c 6/21 $T 17c 5/17 $CCL 17c 5/17 $INTC 40c 5/17 $WBA 20c 5/17, just looking to swing things for minimum 50%
PARA is trying to find a selling partner, so you’ll get some volatility there. You can get calls expiring in 2026 that are deep in the money at $7.5 for $500 right now. Calls are dirt cheap on PFE right now out in 2026 as well deep in the money $20 calls going for $700. Or you can buy 0DTE’s and have $0 by Monday.
didnt you hear, PFE is going out of business. we expect bankruptcy in 2 days.
Why is PFE down to 1998 prices? Aren't they supposed to be a big successful pharma?
I view PFE as an acquirer of technology with sometime good and sometime bad integration. I think their immediate success will be how well the Seagen acquisition does.
It's a stagnant dinosaur of a pharma company; people keep trying to call bottoms in something that, before the recent decline, hadn't done much of anything in 20 years. Maybe it bounces, maybe it gets to a point of being overhated, but it's been a consistently disappointing company for years and the market doesn't have faith in its capital allocation ability given its frequently overpaid for growth. Bunch of people on here were incessantly arguing for it instead of LLY or NVO because "PFE is cheap and they have an obesity drug too" - then the obesity drug trial was a flop and to top it off, they took down FY guidance not long after. Maybe it finally bounces sometime but not sure why people keep being interested in something that has had a lousy last couple of decades or so. It's one thing if something has had an off couple of years and there's a catalyst for things to turn around. It's another if something really hasn't done well for two decades or so, there's too many other companies that are actually well-run to consider as long-term holdings...
Multi year lows… been around for hundreds of years I think. 6% dividend. Im with you on PFE. Index funds are too high for me rn when there’s discount bin deals. Check out The Trading Fraternity on YouTube. he streams live everyday market open to market close. Mostly emphasizes picking up solid companies at discount prices and holding for ten years 🤙
PFE (Pfizer) It has a lot of potential to swing back up. It’s been hovering pretty low (around the 52 week low). It had a small rally today, so I’ll check back in at pre-rally and opening.
I’m holding VZ and PFE which are both lower than pre COVID I think. Really sucks.
Yeah, I mean again, there is something about the stock being cheap, but the question becomes are you willing to hold onto until that turns around. Also the turn around really depends on their drug pipeline and backlog. That's why I don't really do pharma, it's really expensive and there's also no guarantee that the drug will work. I think one thing that's really hard to do at least the last few years, is trying to parse how companies did during the pandemic versus how they are doing now. Like seems like PFE got pulled ahead with a ton of earnings and shot up during the pandemic, but they are going back to how they were before. Like again, if you look at the previous earnings before covid: [https://stockanalysis.com/stocks/pfe/financials/](https://stockanalysis.com/stocks/pfe/financials/) They were growing low single digits or negative growth. So they will probably normalize again at some point, so really putting money in now is hoping the company figures out a way to grow.
>If it's hated you at least gotta take a look, right? Just depends. I mean sometimes it does make sense to be contrarian, but I also believe that if you are investing and not trading, that price is a reflection of fundamentals. I don't really follow pharma, but if you look at the last three years of revenue growth from PFE: 2021: 95%, 2022: 23%, 2023: -42% That's now three years of revenue decreasing. EPS growth over the last 5 years is -27% and EPS Y/Y TTM is now like -93% [https://finviz.com/quote.ashx?t=PFE&p=d](https://finviz.com/quote.ashx?t=PFE&p=d) As a company they offer very little ROIC. Their net margins are also going down: [https://www.tradingview.com/symbols/NYSE-PFE/financials-overview/](https://www.tradingview.com/symbols/NYSE-PFE/financials-overview/) Again, I don't really follow the company, so they could have some drugs in the pipeline, but looking at just their fundamental, not sure why this would be something you want to invest in.
What are ppl's thoughts on PFE? If it's hated you at least gotta take a look, right?
BTO $PFE 29c 6/21 @.45 TP 1.34
Off-the-wall question: Was wondering if there was a hard-and-fast rule about what determines the width between strike prices? I know volume has a bit to play in it, but say for example: BAC/PFE/TFC, etc. have strike prices $0.50 apart, some have $1 apart, while HSY/CBRL/BA, etc. have stock prices $2.50 apart, so forth and so on. Just wondering if, for example, I am interested in options with a $2.50 width, if there was a mechanism to tell which would be which, without having to randomly punch in stock symbols haha. Thanks for your time!
Opened today ( $NKE 100c 6/21 | $PFE 29c 6/21 | $CCL 17c 5/17 | $U 30c 5/17 ) Closed today ( $NCLH 20c 5/17 @1.03 -> 1.33 = 29.1% | $WBA 20c 4/26 @.25 -> .32 = 28% )
Apple. Google PANW PFE ETFs.
BTO $PFE 6/21 29c @.48
1.) Dark Brandon is actually up in a bunch of recent polls. 2.) Polls also don’t really mean shit anymore anyway though. 3.) Abortion is a much much bigger issue than recreational weed, and Dark Brandon doesn’t even have to play that card since the Boomer Religious Zealots played it for him, incredibly badly lol. It’s possible many swing red states will flip on abortion rights alone, and all Biden has had to do is say: “yea we support abortion” lol. The Republicans shot themselves in both feet, and will likely have zero recourse or plan to turn the tide because their party has been taken over by grifters, and the orangest grifter also took control of their campaign piggy bank for his personal use, so they will have no money to fight it anyway. 4.) Politics has little to do with legal weed, at least criminally any more. In the past sure, there were spicy reasons I won’t go into here of why it was made illegal. But now a days? It’s just Big Pharma. Good luck with legalization when LLY, PFE, JNJ, etc. would lose billions to a funny little plant that you can grow in the ground.
PFE if you could end my blue balls and just go buy VKTX for $120 a share I'd appreciate it
You’ll miss the same bump people missed when they slept on PFE after they got gov contracts for Covid jabs. Guaranteed earnings nothing to sleep on
PFE (Pfizer) 30C leaps for 2026 thank me later. Low IV
PFE been trying to break through $28 for a while now. Think it’s going to happen convincingly this week
I like PFE $28 weeklies here. SAVE is gonna print hard. BIDU calls for sure. BOIL probably gonna bounce again here too after pullback
Buying and selling PFE isn’t really “fire and forget.” That’s active management and market timing. Pretty much the exact opposite.
We agree. Buying PFE regularly over time. The dividend is pretty nice on its own. If anyone did their homework on fungal infections, they are one of only three US companies that have the treatment. If one of their cancer treatments get approved they are going to pop overnight. If you have a few years, get some while its low.
Also keeping eye on PFE. Been in NVO but even then Pharma is one bad news and it tanks
PFE probably, but I don't feel as confident as the previous picks. I believe Pharma will come out a huge winner with AI. Maybe the biggest winner of all industries. Maybe not. Mining companies for the long term but they have their own challenges. My biggest play was bonds in past october, when everything took a dive. In hindsight I should have just shoved in NVDA but...
Yup, same for 2000, 2008 and covid time dips. Rest easy - you'll be fine. And it works for other good investments too. About 1/3 of our NW is in individual equities (blue chips, dividend payers, all rated hold+), and even that recovered nicely. Had enough cash to spare this time (cash ran out in 2009....) that I was able to buy some PFE near its low and closed the position right at it's peak before it dipped to where it is now. Fire and forget , with your 20+ year time horizon, is definitely a viable strategy. Enjoy the ride!
Agreed. People don't realize how much their products are used.... Basically every get getting regular vaccination are getting phizer vaccines... all its going to take for PFE to skyrocket will be positive clinical data on a GLP1, which they are working on. It is at a very low price PLUS you are earning a 6% dividend. It pays you to hold it - unlike most the stocks touted on this subreddit.